Cost evaluation and portfolio management optimization for biopharmaceutical product development
The pharmaceutical industry is suffering from declining R&D productivity and yet biopharmaceutical firms have been attracting increasing venture capital investment. Effective R&D portfolio management can deliver above average returns under increasing costs of drug development and the high ri...
| Main Author: | |
|---|---|
| Published: |
University College London (University of London)
2015
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.644423 |